Skip to content


With so much BRCA doom and gloom, there is research to brighten the horizon. Organizations like HeritX are determined to prevent inherited cancer.  

Luckily, HeritX is working diligently to come up with a solution to the BRCA mutation sooner than later, in the form of a possible vaccine to protect against breast cancer. They do this by offering grants for research projects directed toward any given preventative therapies. For instance, can the mutated BRCA1/2 gene be fixed or stabilized? Cancer research funding has been mainly directed toward treatment, and HeritX feels as though the pendulum needs to shift. 

BRCA plus people may eventually feel as though they have other viable options besides super invasive surgeries. Most importantly, HeritX offers hope for our future, as well as opens options for our children who may be affected.

I first came across HeritX at my first BRCA conference. I became intrigued by their determination. Current Research and Development practices, otherwise known as R&D, can take up to 15 years to make a therapy available to the general public. However, with HeritX’s Accelerated R&D, they believe they can accomplish it in less than 10 years.

HeritX is not just worrying about BRCA-related cancers, they are working on preventing them. The founders are either closely connected with a BRCA positive person or a mutation carrier themselves; thus, they are fully invested.

Do you know someone who is focusing their research on preventing inherited cancer? If so, send them to HeritX’s website.

“Our words have power, but our actions shape our lives.”  ~Rachel Hollis